PatientPop, a Santa Monica, California-based startup, has raised $25 million, which it will use to expand its go-to-market capability and innovate its practice growth platform.
Leerink Transformation Partners led the funding round.
The California startup offers a cloud-based, HIPAA-compliant solution that helps providers accelerate new patient acquisition.
“PatientPop makes it easy for healthcare providers to attract more patients, manage online reputation, modernize the patient experience and streamline the front office,” co-founder and co-CEO Luke Kervin said via email.
Its solution also allows organizations to offer online patient scheduling and appointment reminders. The practice growth platform can be integrated into the EMR.
Kervin noted that PatientPop serves healthcare practices in a variety of specialties. Its clients include Speck Health in Seattle; Allegra Dental in Fairfax, Virginia; Got Your Back Total Health in Washington, DC; and Aventura OB/GYN in Florida.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The startup said it has raised $75 million to date. This includes a $10 million raise from Toba Capital in November 2015 and a $3.3 million seed round led by athenahealth in May 2015.
When asked what has changed at PatientPop since 2015, Kervin pointed to the company’s growth.
“We have more than 330 people in the company now, and additional offices,” he said. “We’ve also evolved in the way we do things as a company — to support our growth and maturity, and [the] evolution of our technology solution.”
Photo: aurielaki, Getty Images
